Five companies from different industries are participating in a sustainability summit where they discuss and share their approaches to integrating the triple bottom line (TBL), corporate social responsibility (CSR), and green logistics into their business operations. The companies include:
EcoElectronics Inc. - An electronic device manufacturing company with a focus on environmentally friendly products. The company is committed to reducing its carbon footprint by using recycled materials in its products and minimizing electronic waste.
SocialSolutions Ltd. - A consulting firm specializing in social impact initiatives and community development. Their commitment to social impact involves working closely with local communities, implementing initiatives that empower individuals, and fostering sustainable development.
ProfitablePharma Corp. - A pharmaceutical company committed to balancing financial success with social and environmental responsibility. Beyond financial profitability, the company places a high value on moral pharmaceutical practices. This includes ensuring affordable access to medications and minimizing environmental impact in the manufacturing process.
ModernTrans Logistics - A logistics company that specializes in sustainable and eco-friendly carriage solutions. The company invests in a modern and eco-friendly fleet, utilizing alternative fuels and optimizing routes to reduce emissions.
TechInnovate Innovations - A technology company striving to incorporate green practices in its supply chain and operations. Their commitment includes sourcing ethically produced raw materials and adopting energy-efficient manufacturing processes, minimizing environmental impact while driving innovation in the technology sector.
You are required, for each company, to align the primary focus area and recommend the key factor.
Q: What is the recommended key factor for ProfitablePharma Corp.?
Show Answer
Hide Answer
Correct Answer:
B
The recommended key factor for ProfitablePharma Corp. is 'Ethical Business Practices', ensuring they maintain moral pharmaceutical practices and provide affordable access to medications. [P 166-169]
